What is the list of typical topical corticosteroid (steroid) creams from strongest to weakest for a general adult population with no specific medical history?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Topical Corticosteroid Potency Ranking: Strongest to Weakest

Topical corticosteroids are classified into seven potency classes, ranging from Class I (super-high/ultra-high potency) to Class VII (lowest potency), with selection based on the anatomical site, patient age, and severity of the inflammatory condition. 1, 2

Class I: Super-High Potency (Strongest)

  • Clobetasol propionate 0.05% (cream, ointment, gel, foam) 2
  • Betamethasone dipropionate 0.05% (optimized ointment) 2
  • Halobetasol propionate 0.05% 2

Clinical use: Reserved for severe inflammatory conditions on thick-skinned areas (palms, soles); limited to 2-3 weeks maximum duration; avoid on face, genitals, and intertriginous areas 2

Class II: High Potency

  • Fluocinonide 0.05% (cream, ointment, gel) 2
  • Desoximetasone 0.25% (cream, ointment) 2
  • Betamethasone dipropionate 0.05% (standard ointment) 2
  • Mometasone furoate 0.1% (ointment) 2

Clinical use: Appropriate for moderate-to-severe dermatoses on body areas; use up to 12 weeks with monitoring 2

Class III: Upper-Mid Potency

  • Triamcinolone acetonide 0.5% (cream, ointment) 2
  • Fluticasone propionate 0.005% (ointment) 2
  • Betamethasone valerate 0.1% (ointment) 2

Clinical use: Suitable for moderate inflammatory conditions on trunk and extremities; can be used for up to 12 weeks 3, 2

Class IV: Mid Potency

  • Triamcinolone acetonide 0.1% (cream, ointment) 2
  • Mometasone furoate 0.1% (cream) 2
  • Fluocinolone acetonide 0.025% 2
  • Hydrocortisone valerate 0.2% 2

Clinical use: First-line for many inflammatory dermatoses on body areas; safe for extended use with monitoring 2

Class V: Lower-Mid Potency

  • Hydrocortisone butyrate 0.1% 2
  • Fluticasone propionate 0.05% (cream) 2
  • Betamethasone valerate 0.1% (cream) 2
  • Prednicarbate 0.1% 2

Clinical use: Appropriate for mild-to-moderate conditions; safer for facial use in adults when necessary 2

Class VI: Low Potency

  • Alclometasone dipropionate 0.05% 1
  • Desonide 0.05% 1
  • Fluocinolone acetonide 0.01% 1

Clinical use: Preferred for facial and intertriginous areas; safe for children and sensitive skin; no specified time limit for use 1, 2

Class VII: Lowest Potency (Weakest)

  • Hydrocortisone 2.5% 1, 4
  • Hydrocortisone 1% 1, 4
  • Hydrocortisone 0.5-1% (over-the-counter) 1

Clinical use: Safest option for face, neck, genitals, and children; can be used for extended periods with appropriate supervision; minimal risk of atrophy 1, 4, 5

Critical Selection Principles

Anatomical site is the primary determinant of potency selection: Face and neck require Class VI-VII (low-to-lowest potency) due to thinner skin, increased percutaneous absorption, and higher risk of atrophy, telangiectasias, and perioral dermatitis 1, 5, 2

Duration guidelines by potency class:

  • Class I (super-high): Maximum 2-3 weeks 2
  • Class II-III (high to upper-mid): Up to 12 weeks 2
  • Class IV-V (mid to lower-mid): Extended use with monitoring 2
  • Class VI-VII (low to lowest): No specified time limit 2

Common pitfall: "Steroid phobia" leads to undertreatment—the vast majority of prescribed topical corticosteroids are mild potency with minimal risk of harm when used appropriately 6

Formulation matters: Ointments are more potent than creams of the same concentration due to enhanced penetration; use creams for weeping/acute lesions and ointments for dry/chronic conditions 4, 2

References

Guideline

Mild Potency Topical Corticosteroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Topical Corticosteroids: Choice and Application.

American family physician, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hydrocortisone Prescription for Skin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Duration of Low-Dose Corticosteroid Cream Use on the Face

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.